- 专利标题： Antisense modulation of MyD88 expression
-
申请号： US10673063申请日： 2003-09-26
-
公开(公告)号： US07033830B2公开(公告)日： 2006-04-25
- 发明人: James Karras , Kenneth Dobie
- 申请人： James Karras , Kenneth Dobie
- 申请人地址： US CA Carlsbad
- 专利权人： ISIS Pharmaceuticals, Inc.
- 当前专利权人： ISIS Pharmaceuticals, Inc.
- 当前专利权人地址： US CA Carlsbad
- 代理机构： ISIS Patent Department
- 代理商 Cozen O'Connor, P.C.
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; C12N15/85 ; C12N15/86 ; C07H21/04
摘要：
Antisense compounds, compositions and methods are provided for modulating the expression of MyD88. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding MyD88. Methods of using these compounds for modulation of MyD88 expression and for treatment of diseases associated with expression of MyD88 are provided.
公开/授权文献
- US20040038926A1 Antisense modulation of MyD88 expression 公开/授权日：2004-02-26
信息查询
